You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

yy-20394

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T/NK Cell Lymphoma (R/R PTCL) Trial (YY-20394)

Recruiting
  • Peripheral T/NK Cell Lymphoma (R/R PTCL)
  • YY-20394
  • Houston, Texas
    MD Anderson Cancer Center
Oct 19, 2022

YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

Not yet recruiting
  • Effectiveness，Safety，Thymic Cancer
  • YY-20394
  • (no location specified)
Jul 20, 2021

Relapsed or Refractory Peripheral T-Cell Lymphoma Trial in Tianjin (YY-20394)

Recruiting
  • Relapsed or Refractory Peripheral T-Cell Lymphoma
  • YY-20394
  • Tianjin, Tianjin, China
    Hematology Hospital of Chinese Academy of Medical Sciences
Jan 25, 2021

Diffuse Large B Cell Lymphoma Trial (YY-20394)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • YY-20394
  • (no location specified)
Aug 3, 2020

Follicular Lymphoma Trial (YY-20394)

Not yet recruiting
  • Follicular Lymphoma
  • YY-20394
  • (no location specified)
May 6, 2020

Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Marginal Zone Lymphoma Trial (YY-20394)

Unknown status
  • Small Lymphocytic Lymphoma
  • +4 more
  • YY-20394
  • (no location specified)
Feb 19, 2020

Advanced Solid Tumor Trial in Shanghai (YY-20394)

Unknown status
  • Advanced Solid Tumor
  • YY-20394
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Aug 7, 2019

B-cell Lymphoma Recurrent, B-cell Chronic Lymphocytic Leukemia Trial in Beijing, Nanjing, Tianjin (YY-20394)

Unknown status
  • B-cell Lymphoma Recurrent
  • B-cell Chronic Lymphocytic Leukemia
  • YY-20394
  • Beijing, Beijing, China
  • +2 more
Dec 6, 2018